why choose us

First received: September 21, 2023

Clinical Trial: Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Atopic Dermatitis

Study Type: INTERVENTIONAL


Official Title: A Multinational, Multicenter, Double-blind, Placebo-controlled Phase 2 Study to Evaluate Efficacy and Safety of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis

Brief Summary: This is a multinational, multicenter, double-blind, placebo-controlled, parallel-group Phase 2, 3-arm study in adult participants with moderate to severe AD who are inadequately controlled with topical therapies or for whom such topical therapies are inadvisable and who are candidates for systemic therapy.Participants will be randomized to receive SAR444656 dose 1, SAR444656 dose 2 or matching placebo.Participants who meet inclusion/exclusion criteria will be stratified for randomization by severity of AD…

Read more